![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](bh2143contents.gif)
Acta Cryst. (2007). E63, m3030-m3031 [ doi:10.1107/S1600536807057649 ]
Abstract: The asymmetric unit of the title complex, aqua[1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylato](1,10-phenanthroline)copper(II) nitrate dihydrate, [Cu(C19H21FN3O3)(C12H8N2)(H2O)]NO3·2H2O, contains one [Cu(erx)(phen)(H2O)]+ cation, one NO3- anion and two solvent water molecules (erx is enrofloxacin and phen is 1,10-phenanthroline). The CuII ion adopts a slightly distorted square-pyramidal geometry, coordinated by two O atoms of the erx ligand and two N atoms of the phen ligand in the basal plane, and by a water molecule in the apical position. The CuII ion deviates from the basal plane by 0.1439 (7) Å. The piperazine ring belonging to erx has a slightly twisted chair conformation. Coordinated and uncoordinated water molecules participate in a hydrogen-bonding network including both cations and anions, to produce a three-dimensional supramolecular structure.
Online 16 November 2007
Copyright © International Union of Crystallography
IUCr Webmaster